SIBIONICS Announces Participation in the 17th International Conference on Advanced Technologies and Treatments for Diabetes

Our Bureau

SIBIONICS, the world’s third-largest continuous glucose monitoring (CGM) brand, announced that it will participate in the International Diabetes Technology Exhibition at the 17th Symposium on Diabetes at the 17th Symposium on Diabetese International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Florence, Italy, March 6-9, 2024. It will be […]

MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment

Our Bureau

MediThinQ, a pioneering Korean startup specialising in extended reality (XR) wearable displays for surgery, is making waves as the first Asian startup to globally launch XR surgical displays. The company has successfully secured significant deals with industry giants, including Medtronic USA and Japan, marking a substantial milestone in its international expansion efforts. In […]

Tareen Dermatology Sponsors 9th Annual Palentine’s Event for Minnesota’s Big Brother, Big Sister Organization, with Momento in St. Paul

Our Bureau

Tareen Dermatology sponsored its 9th annual Palentine’s event for Minnesota’s Big Brother, Big Sister organization. This event, a cherished tradition for several years, aims to bring joy and create lasting memories for 25 pairs of “Bigs” and “Littles” around Valentine’s Day. This year, Momento, owned by Morrissey Hospitality, was the official catering […]

Record-making Partnerships: IntraCare Continues to Strengthen Presence in Arizona as Three More Clinics Sign on in December

Our Bureau

IntraCare, a prominent Texas-based MSO, gained record growth in the month of December 2023 upon signing partnership agreements with three medical entities in Arizona. This adds another 16 care practitioners to IntraCare’s provider network. The strategic partnerships with Atembis, LLC; Sun Lake Family Physicians, LLC; and Family Practice Specialists are a significant step towards […]

Medicom Recognized as One of the Most Promising Health IT Imaging Vendors of 2024 by KLAS Research

Our Bureau

Medicom Technologies, Inc. (Medicom) proudly announces its recognition as one of the most promising IT vendors in Imaging in the Emerging HCIT Companies 2024 KLAS Research report. In a recent report released on January 16th, 2024, KLAS Research showcased Medicom alongside other healthcare IT vendors across various market segments. KLAS Research conducts annual interviews with healthcare […]

Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma

Our Bureau

The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, welcomes the U.S. Food and Drug Administration (FDA) decision to approve Iovance Biotherapeutics’ AMTAGVI™ (lifileucel) for the treatment of patients with advanced melanoma in the second line treatment setting. AMTAGVI is the first individualized Tumor Infiltrating Lymphocyte (TIL) therapy […]

China Medical University Hospital (CMUH) in Taiwan Upgrades Smart Healthcare with Gen AI

Our Bureau

China Medical University Hospital (CMUH) in Taiwan announced its collaboration with Google Cloud in mid-December 2023. Using Google Cloud’s generative AI technology, including MedLM, which is a large language model built on Med-PaLM 2, CMUH has developed a comprehensive “AI-assisted Physician” system which aims to assist healthcare professionals in disease diagnosis, treatment planning, patient education, and […]

Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor

Our Bureau

Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced it received approval of registrational phase III clinical trial of the combination therapy between its novel KRAS G12C inhibitor glecirasib and novel SHP2 inhibitor JAB-3312. JAB-3312 is the first SHP2 inhibitor entered into phase III study globally in combination with KRAS […]

New clinical trial shows that algae-based omega-3 lecithin AlmegaPL® provides better cardiovascular health support compared to traditional omega-3 fish oils

Our Bureau

Qualitas Health, LLC (dba iwi life) The results of a new clinical trial show evidence that the microalgae-derived AlmegaPL®, the foundational ingredient produced by iwi life™, delivers clinically relevant results decreasing triglycerides by 14% and remnant cholesterol such as very-low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL) by up to 25%.1,2  “This marks […]

Subscribe Now